BioAtla Statistics
Total Valuation
BioAtla has a market cap or net worth of $96.67 million. The enterprise value is $36.67 million.
Important Dates
The next confirmed earnings date is Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BioAtla has 48.34 million shares outstanding. The number of shares has increased by 9.01% in one year.
| Shares Outstanding | 48.34M |
| Shares Change (YoY) | +9.01% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 9.00% |
| Owned by Institutions (%) | 39.45% |
| Float | 37.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.08 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.81, with a Debt / Equity ratio of 0.05.
| Current Ratio | 3.81 |
| Quick Ratio | 3.53 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -134.14% and return on invested capital (ROIC) is -85.51%.
| Return on Equity (ROE) | -134.14% |
| Return on Assets (ROA) | -55.37% |
| Return on Capital (ROIC) | -85.51% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.61M |
| Employee Count | 65 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.11% in the last 52 weeks. The beta is 1.02, so BioAtla's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | +8.11% |
| 50-Day Moving Average | 1.87 |
| 200-Day Moving Average | 2.14 |
| Relative Strength Index (RSI) | 52.49 |
| Average Volume (20 Days) | 789,982 |
Short Selling Information
The latest short interest is 5.24 million, so 10.85% of the outstanding shares have been sold short.
| Short Interest | 5.24M |
| Short Previous Month | 4.47M |
| Short % of Shares Out | 10.85% |
| Short % of Float | 13.99% |
| Short Ratio (days to cover) | 2.96 |
Income Statement
| Revenue | n/a |
| Gross Profit | -86.12M |
| Operating Income | -109.99M |
| Pretax Income | -104.56M |
| Net Income | -104.56M |
| EBITDA | -108.88M |
| EBIT | -109.99M |
| Earnings Per Share (EPS) | -$2.18 |
Full Income StatementBalance Sheet
The company has $61.66 million in cash and $1.66 million in debt, giving a net cash position of $60.00 million or $1.24 per share.
| Cash & Cash Equivalents | 61.66M |
| Total Debt | 1.66M |
| Net Cash | 60.00M |
| Net Cash Per Share | $1.24 |
| Equity (Book Value) | 31.37M |
| Book Value Per Share | 0.65 |
| Working Capital | 49.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$107.29 million and capital expenditures -$33,000, giving a free cash flow of -$107.32 million.
| Operating Cash Flow | -107.29M |
| Capital Expenditures | -33,000 |
| Free Cash Flow | -107.32M |
| FCF Per Share | -$2.22 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |